[The behavior of transaminases (GOT, GPT) and dehydrogenases (LDH, MDH) in serum in recurrent carcinoma].
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood*; D001219:Aspartate Aminotransferases / Q000097:blood*; D001943:Breast Neoplasms / Q000201:enzymology*; D004796:Clinical Enzyme Tests; D003110:Colonic Neoplasms / Q000201:enzymology; D005260:Female; D005833:Genital Neoplasms, Female / Q000201:enzymology*; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood*; D008291:Malate Dehydrogenase / Q000097:blood*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000201:enzymology*; D010051:Ovarian Neoplasms / Q000097:blood; D002583:Uterine Cervical Neoplasms / Q000201:enzymology; D014625:Vaginal Neoplasms / Q000201:enzymology; D014846:Vulvar Neoplasms / Q000201:enzymology
D007770:L-Lactate Dehydrogenase; D008291:Malate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Das Verhalten der Transaminasen (GOT, GPT) und Dehydrogenasen (LDH, MDH) im Serum beim Carcinomrezidiv.